Literature DB >> 26576103

Research progress and prospects of markers for liver cancer stem cells.

Cheng-Pei Zhu1, An-Qiang Wang1, Hao-Hai Zhang1, Xue-Shuai Wan1, Xiao-Bo Yang1, Shu-Guang Chen1, Hai-Tao Zhao1.   

Abstract

Liver cancer is a common malignancy and surgery is the main treatment strategy. However, the prognosis is still poor because of high frequencies of postoperative recurrence and metastasis. In recent years, cancer stem cell (CSC) theory has evolved with the concept of stem cells, and has been applied to oncological research. According to cancer stem cell theory, liver cancer can be radically cured only by eradication of liver cancer stem cells (LCSCs). This notion has lead to the isolation and identification of LCSCs, which has become a highly researched area. Analysis of LCSC markers is considered to be the primary method for identification of LCSCs. Here, we provide an overview of the current research progress and prospects of surface markers for LCSCs.

Entities:  

Keywords:  CD90; Epithelial cell adhesion molecule; Hepatocellular carcinoma; Liver cancer stem cells; Surface markers

Mesh:

Substances:

Year:  2015        PMID: 26576103      PMCID: PMC4641136          DOI: 10.3748/wjg.v21.i42.12190

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  60 in total

1.  Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma.

Authors:  Zhe Guo; Le-Qun Li; Jing-Hang Jiang; Chao Ou; Li-Xia Zeng; Bang-De Xiang
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

2.  Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma.

Authors:  Keisuke Kohga; Tomohide Tatsumi; Tetsuo Takehara; Hinako Tsunematsu; Satoshi Shimizu; Masashi Yamamoto; Akira Sasakawa; Takuya Miyagi; Norio Hayashi
Journal:  J Hepatol       Date:  2010-03-24       Impact factor: 25.083

3.  CD13 is a therapeutic target in human liver cancer stem cells.

Authors:  Naotsugu Haraguchi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Masahisa Ohkuma; Ho Min Kim; Hirofumi Akita; Daisuke Takiuchi; Hisanori Hatano; Hiroaki Nagano; Graham F Barnard; Yuichiro Doki; Masaki Mori
Journal:  J Clin Invest       Date:  2010-08-09       Impact factor: 14.808

4.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Authors:  Stephanie Ma; Kwok-Wah Chan; Liang Hu; Terence Kin-Wah Lee; Jana Yim-Hung Wo; Irene Oi-Lin Ng; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2007-04-15       Impact factor: 22.682

5.  A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells.

Authors:  Joan Fernando; Andrea Malfettone; Edgar B Cepeda; Roser Vilarrasa-Blasi; Esther Bertran; Giulia Raimondi; Àngels Fabra; Alberto Alvarez-Barrientos; Pedro Fernández-Salguero; Conrado M Fernández-Rodríguez; Gianluigi Giannelli; Patricia Sancho; Isabel Fabregat
Journal:  Int J Cancer       Date:  2014-08-04       Impact factor: 7.396

6.  Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.

Authors:  W Song; H Li; K Tao; R Li; Z Song; Q Zhao; F Zhang; K Dou
Journal:  Int J Clin Pract       Date:  2008-05-08       Impact factor: 2.503

7.  Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

Authors:  Stephanie Ma; Kwok Wah Chan; Terence Kin-Wah Lee; Kwan Ho Tang; Jana Yim-Hung Wo; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

8.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

9.  Effect of CD133/prominin-1 antisense oligodeoxynucleotide on in vitro growth characteristics of Huh-7 human hepatocarcinoma cells and U251 human glioma cells.

Authors:  Jie Yao; Tao Zhang; Jinghua Ren; Minxia Yu; Gang Wu
Journal:  Oncol Rep       Date:  2009-10       Impact factor: 3.906

10.  Human hepatic stem cells from fetal and postnatal donors.

Authors:  Eva Schmelzer; Lili Zhang; Andrew Bruce; Eliane Wauthier; John Ludlow; Hsin-lei Yao; Nicholas Moss; Alaa Melhem; Randall McClelland; William Turner; Michael Kulik; Sonya Sherwood; Tommi Tallheden; Nancy Cheng; Mark E Furth; Lola M Reid
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

View more
  12 in total

1.  Cancer stem cell-associated microRNAs: searching for markers and targets in hepatocellular carcinoma.

Authors:  Ruben Hernandez-Alcoceba; Puri Fortes
Journal:  Transl Gastroenterol Hepatol       Date:  2016-03-16

2.  Hepatocyte selection medium-enriched hepatocellular carcinoma cells are positive for α-fetoprotein and CD44.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Oncol Lett       Date:  2017-05-24       Impact factor: 2.967

Review 3.  Diabetes mellitus and metformin in hepatocellular carcinoma.

Authors:  Koji Fujita; Hisakazu Iwama; Hisaaki Miyoshi; Joji Tani; Kyoko Oura; Tomoko Tadokoro; Teppei Sakamoto; Takako Nomura; Asahiro Morishita; Hirohito Yoneyama; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 4.  Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.

Authors:  An-Qiang Wang; Yong-Chang Zheng; Juan Du; Cheng-Pei Zhu; Han-Chun Huang; Shan-Shan Wang; Liang-Cai Wu; Xue-Shuai Wan; Hao-Hai Zhang; Ruo-Yu Miao; Xin-Ting Sang; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

5.  Comprehensive Analysis of Aldehyde Dehydrogenases (ALDHs) and Its Significant Role in Hepatocellular Carcinoma.

Authors:  Senbang Yao; Wenjun Chen; He Zuo; Ziran Bi; Xiuqing Zhang; Lulian Pang; Yanyan Jing; Xiangxiang Yin; Huaidong Cheng
Journal:  Biochem Genet       Date:  2021-12-20       Impact factor: 2.220

6.  High-throughput flow cytometry screening of human hepatocellular carcinoma reveals CD146 to be a novel marker of tumor-initiating cells.

Authors:  Kui Chen; Avrilynn Ding; Yu Ding; Anand Ghanekar
Journal:  Biochem Biophys Rep       Date:  2016-08-12

7.  Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling.

Authors:  Qiong Xu; Hai-Xu Xu; Jin-Ping Li; Song Wang; Zheng Fu; Jing Jia; Li Wang; Zhi-Feng Zhu; Rong Lu; Zhi Yao
Journal:  Oncotarget       Date:  2017-03-07

8.  Small Nucleolar RNA Host Gene 1 (SNHG1) and Chromosome 2 Open Reading Frame 48 (C2orf48) as Potential Prognostic Signatures for Liver Cancer by Constructing Regulatory Networks.

Authors:  Hui Zhang; Changhua Zhuo; Dong Zhou; Mingji Zhang; Fan Zhang; Minyong Chen; Shaohua Xu; Zhaoshuo Chen
Journal:  Med Sci Monit       Date:  2020-02-09

Review 9.  Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer.

Authors:  Fang Huang; Bin-Rong Wang; Ye-Qing Wu; Fan-Chao Wang; Jian Zhang; Yi-Gang Wang
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

10.  Generation and characterization of hepatocellular carcinoma cell lines with enhanced cancer stem cell potential.

Authors:  Julienne K Muenzner; Philipp Kunze; Pablo Lindner; Sandra Polaschek; Kira Menke; Markus Eckstein; Carol I Geppert; Pithi Chanvorachote; Tobias Baeuerle; Arndt Hartmann; Regine Schneider-Stock
Journal:  J Cell Mol Med       Date:  2018-10-02       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.